USD 1.1
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 2.15 Billion | 33.39 Million | -725.16 Million | 2.29 Billion | 671.5 Million |
Net Income | 1.3 Billion | 558.72 Million | 905.4 Million | 920.92 Million | 643.53 Million |
Depreciation & Amortization | 937.13 Million | 870.57 Million | 816.13 Million | 932.2 Million | 921.1 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -556.05 Million | -1.47 Billion | -2.23 Billion | 324.93 Million | -1.72 Billion |
Other non-cash items | 105.42 Million | 49.61 Million | 17.43 Million | -50.7 Million | 832.92 Million |
Investing Cash Flow | -409.07 Million | -347.44 Million | -401.17 Million | -109.93 Million | -397.93 Million |
Investments in PPE | -448.31 Million | -379.12 Million | -396.59 Million | -235.85 Million | -415.16 Million |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | 100.65 Million | - |
Other Investing Activities | -12.59 Million | 20.77 Million | -16.1 Million | -830 Thousand | 17.22 Million |
Financing Cash Flow | -1.39 Billion | 417.98 Million | 133.61 Million | -1.61 Billion | -537.24 Million |
Debt repayment | -506.88 Million | -1.29 Billion | -1.13 Billion | -836.34 Million | -404.68 Million |
Dividends payments | -237.1 Million | -291.29 Million | -379.36 Million | -203.23 Million | -392.91 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -546.86 Million | 865.85 Million | 480 Thousand | -729.2 Million | 260.34 Million |
Accounts receivables | -192.55 Million | -112.64 Million | 427.36 Million | -2.24 Million | 42.4 Million |
Accounts payables | - | - | - | - | - |
Inventory | -292.25 Million | -1.16 Billion | -2.44 Billion | 346.01 Million | -1.55 Billion |
Other working capital | -57.51 Million | -92.34 Million | 282.21 Million | -131.85 Million | -216.74 Million |
Cash at beginning of period | 748.62 Million | 671.54 Million | 1.65 Billion | 1.02 Billion | 1.3 Billion |
Cash at end of period | 1.09 Billion | 748.62 Million | 671.54 Million | 1.65 Billion | 1.02 Billion |
Capital Expenditure | -448.31 Million | -379.12 Million | -396.59 Million | -235.85 Million | -415.16 Million |
Effect of forex changes on cash | -13.2 Million | -26.85 Million | 10.5 Million | 55.4 Million | -10.52 Million |
Net cash flow / Change in cash | 347.51 Million | 77.08 Million | -982.21 Million | 625.44 Million | -274.2 Million |
Free Cash Flow | 1.71 Billion | -345.73 Million | -1.12 Billion | 2.05 Billion | 256.34 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 92.73 Million | 1.3 Billion | 92.73 Million | 413.6 Million | 413.6 Million | -9.71 Million |
Depreciation & Amortization | - | 937.13 Million | - | 233.85 Million | 233.85 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -556.05 Million | - | - | - | - |
Other non-cash items | -92.73 Million | 105.42 Million | -92.73 Million | 154.06 Million | 154.06 Million | 9.71 Million |
Investing Cash Flow | - | -409.07 Million | - | -147.02 Million | -147.02 Million | - |
Investments in PPE | - | -448.31 Million | - | -142.84 Million | -142.84 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -12.59 Million | - | -4.18 Million | -4.18 Million | - |
Financing Cash Flow | - | -1.39 Billion | - | -385.75 Million | -385.75 Million | - |
Debt repayment | - | -506.88 Million | - | - | - | - |
Dividends payments | - | -237.1 Million | - | -50.8 Million | -50.8 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -546.86 Million | - | -334.94 Million | -334.94 Million | - |
Accounts receivables | - | -192.55 Million | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | -292.25 Million | - | - | - | - |
Other working capital | - | -57.51 Million | - | - | - | - |
Cash at beginning of period | - | 748.62 Million | - | - | - | - |
Cash at end of period | - | 1.09 Billion | - | 254.59 Million | 254.59 Million | - |
Capital Expenditure | - | -448.31 Million | - | -142.84 Million | -142.84 Million | - |
Effect of forex changes on cash | - | -13.2 Million | - | -14.15 Million | -14.15 Million | - |
Net cash flow / Change in cash | - | 347.51 Million | - | 254.59 Million | 254.59 Million | - |
Free Cash Flow | - | 1.71 Billion | - | 658.68 Million | 658.68 Million | - |
153A
CTIHY
300868
001300
SYGCF
HRN